Medication adherence halves COPD patients’ hospitalisation risk

In a study of claims data for 13,557 COPD patients in Switzerland, patients with high medication adherence (daily medication reserve of 80% to 100%) are 51% less likely to incur exacerbation, than patients with the lowest medication adherence (daily medication reserve of 0% to 20%). The study shows that medication adherence varies strongly among Swiss COPD patients. Furthermore, high medication adherence immensely decreases the risk of hospitalized exacerbations.

Medication adherence is vital for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) to mitigate long-term consequences.

Helicon Health, a leader in delivering healthcare virtually has an agreement to distribute and integrate the Hailie® Smart Inhaler sensor range and cloud data services on behalf of Adherium Limited (“Adherium”; ASX: ADR). Adherium is a leader in respiratory eHealth, remote patient monitoring and virtual ward solutions.

A study published January 2024: Cost-effectiveness and impact on healthcare utilization of interventions to improve medication adherence and outcomes in asthma and COPD: A systematic literature review

More Helicon News

About the Author
Sander ten Veldhuijs
Sander ten Veldhuijs is a NIA Fellow. The NIA is helping Sander and the Helicon Health team focus on accelerating the Hailie® Digital Smart Inhaler, a bluetooth-based medication adherence solution. Hailie® uses sensors that fit onto regular inhalers to offer real-time feedback to patients via the Hailie® app and to Clinicians via a secure web portal.
Share this post
Share This